Market Executive Summary
Due to the COVID-19 pandemic, the global Viral Vectors market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Retroviral Vectors accounting for % of the Viral Vectors global market in 2022, is projected to value US$ million by 2029, growing at a revised ?GR from 2023 to 2029. While Cancers segment is altered to an ?GR throughout this forecast period.
The global key companies of Viral Vectors include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm and FUJIFILM Diosynth Biotechnologies, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Viral Vectors market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Viral Vectors market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Viral Vectors market. Readers of the report can become informed about current and future trends of the global Viral Vectors market and how they will impact market growth during the forecast period.
By Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Segment by Type
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Herpes Simplex Virus Vectors
Chimeric Viral Vectors
Others
Segment by Application
Cancers
Inherited Disorders
Viral Infections
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Viral Vectors in global and regional level.
Chapter 3: Detailed analysis of Viral Vectors companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Viral Vectors revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
Related Reports:
Global Advanced Cell Therapies Market Analysis, Share, Opportunities, Growth Trends and Forecast Till 2030
Global Gene Therapy Market Analysis, Growth Drivers, Trends, Recent Developments, and Forecast Till 2030
Global T-Cell Therapy Market Analysis, Share, Opportunities, Growth Trends and Forecast Till 2030
Adeno-Associated Virus (AAV) Gene Therapy Market Analysis, Share, Growth Drivers, Segmentation Analysis and Forecast Till 2030
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Retroviral Vectors
1.2.3 Lentiviral Vectors
1.2.4 Adenoviral Vectors
1.2.5 Herpes Simplex Virus Vectors
1.2.6 Chimeric Viral Vectors
1.2.7 Others
1.3 Market by Application
1.3.1 Global Viral Vectors Market Growth Rate by Application: 2018 VS 2022 VS 2029
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Viral Vectors Market Size (2018-2029)
2.2 Viral Vectors Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2029
2.3 Global Viral Vectors Market Size by Region (2018-2023)
2.4 Global Viral Vectors Market Size Forecast by Region (2024-2029)
2.5 Global Top 10 Viral Vectors Countries Ranking by Market Size
3 Viral Vectors Competitive by Company
3.1 Global Viral Vectors Revenue by Players
3.1.1 Global Viral Vectors Revenue by Players (2018-2023)
3.1.2 Global Viral Vectors Market Share by Players (2018-2023)
3.2 Global Viral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Viral Vectors Revenue
3.4 Global Viral Vectors Market Concentration Ratio
3.4.1 Global Viral Vectors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors Revenue in 2022
3.5 Global Key Players of Viral Vectors Head office and Area Served
3.6 Global Key Players of Viral Vectors, Product and Application
3.7 Global Key Players of Viral Vectors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Viral Vectors Breakdown Data by Type
4.1 Global Viral Vectors Historic Revenue by Type (2018-2023)
4.2 Global Viral Vectors Forecasted Revenue by Type (2024-2029)
5 Global Viral Vectors Breakdown Data by Application
5.1 Global Viral Vectors Historic Market Size by Application (2018-2023)
5.2 Global Viral Vectors Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Viral Vectors Revenue by Company (2021-2023)
6.2 North America Viral Vectors Revenue by Type (2018-2029)
6.3 North America Viral Vectors Revenue by Application (2018-2029)
6.4 North America Viral Vectors Revenue by Country (2018-2029)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Viral Vectors Revenue by Company (2021-2023)
7.2 Europe Viral Vectors Revenue by Type (2018-2029)
7.3 Europe Viral Vectors Revenue by Application (2018-2029)
7.4 Europe Viral Vectors Revenue by Country (2018-2029)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Viral Vectors Revenue by Company (2021-2023)
8.2 Asia Pacific Viral Vectors Revenue by Type (2018-2029)
8.3 Asia Pacific Viral Vectors Revenue by Application (2018-2029)
8.4 Asia Pacific Viral Vectors Revenue by Region (2018-2029)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Viral Vectors Revenue by Company (2021-2023)
9.2 Latin America Viral Vectors Revenue by Type (2018-2029)
9.3 Latin America Viral Vectors Revenue by Application (2018-2029)
9.4 Latin America Viral Vectors Revenue by Country (2018-2029)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Viral Vectors Revenue by Company (2021-2023)
10.2 Middle East and Africa Viral Vectors Revenue by Type (2018-2029)
10.3 Middle East and Africa Viral Vectors Revenue by Application (2018-2029)
10.4 Middle East and Africa Viral Vectors Revenue by Country (2018-2029)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 BioReliance
11.1.1 BioReliance Company Details
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vectors Products and Services
11.1.4 BioReliance Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.1.5 BioReliance Viral Vectors SWOT Analysis
11.1.6 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Details
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vectors Products and Services
11.2.4 Cobra Biologics Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.2.5 Cobra Biologics Viral Vectors SWOT Analysis
11.2.6 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Details
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vectors Products and Services
11.3.4 Oxford BioMedica Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.3.5 Oxford BioMedica Viral Vectors SWOT Analysis
11.3.6 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vectors Products and Services
11.4.4 UniQure Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.4.5 UniQure Viral Vectors SWOT Analysis
11.4.6 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Details
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vectors Products and Services
11.5.4 FinVector Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.5.5 FinVector Viral Vectors SWOT Analysis
11.5.6 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Details
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vectors Products and Services
11.6.4 MolMed Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.6.5 MolMed Viral Vectors SWOT Analysis
11.6.6 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Details
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vectors Products and Services
11.7.4 MassBiologics Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.7.5 MassBiologics Viral Vectors SWOT Analysis
11.7.6 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Details
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vectors Products and Services
11.8.4 Richter-Helm Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.8.5 Richter-Helm Viral Vectors SWOT Analysis
11.8.6 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Details
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Products and Services
11.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.9.5 FUJIFILM Diosynth Biotechnologies Viral Vectors SWOT Analysis
11.9.6 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Details
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vectors Products and Services
11.10.4 Lonza Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.10.5 Lonza Viral Vectors SWOT Analysis
11.10.6 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Details
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vectors Products and Services
11.11.4 Aldevron Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Details
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vectors Products and Services
11.12.4 Eurogentec Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Details
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vectors Products and Services
11.13.4 Cell and Gene Therapy Catapult Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Details
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vectors Products and Services
11.14.4 Biovian Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.14.5 Biovian Recent Development
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Details
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Products and Services
11.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.16 VGXI
11.16.1 VGXI Company Details
11.16.2 VGXI Business Overview
11.16.3 VGXI Viral Vectors Products and Services
11.16.4 VGXI Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.16.5 VGXI Recent Development
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Details
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Viral Vectors Products and Services
11.17.4 PlasmidFactory Viral Vectors Revenue in Viral Vectors Business (2018-2023)
11.17.5 PlasmidFactory Recent Development
12 Viral Vectors Market Dynamics
12.1 Viral Vectors Industry Trends
12.2 Viral Vectors Market Drivers
12.3 Viral Vectors Market Challenges
12.4 Viral Vectors Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures
List of Tables
Table 1. Global Viral Vectors Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Retroviral Vectors
Table 3. Key Players of Lentiviral Vectors
Table 4. Key Players of Adenoviral Vectors
Table 5. Key Players of Herpes Simplex Virus Vectors
Table 6. Key Players of Chimeric Viral Vectors
Table 7. Key Players of Others
Table 8. Global Viral Vectors Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 9. Global Viral Vectors Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
Table 10. Global Viral Vectors Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Viral Vectors Revenue Forecast by Region (2024-2029) & (US$ Million)
Table 12. Global Viral Vectors Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Table 13. Global Viral Vectors Revenue by Players (2018-2023) & (US$ Million)
Table 14. Global Viral Vectors Market Share by Players (2018-2023)
Table 15. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors as of 2022)
Table 16. Ranking of Global Top Viral Vectors Companies by Revenue (US$ Million) in 2022
Table 17. Global 5 Largest Players Market Share by Viral Vectors Revenue (CR5 and HHI) & (2018-2023)
Table 18. Global Key Players of Viral Vectors, Headquarters and Area Served
Table 19. Global Key Players of Viral Vectors, Product and Application
Table 20. Global Key Players of Viral Vectors, Date of Enter into This Industry
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Viral Vectors Market Size by Type (2018-2023) & (US$ Million)
Table 23. Global Viral Vectors Revenue Market Share by Type (2018-2023)
Table 24. Global Viral Vectors Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 25. Global Viral Vectors Revenue Market Share by Type (2024-2029)
Table 26. Global Viral Vectors Market Size by Application (2018-2023) & (US$ Million)
Table 27. Global Viral Vectors Revenue Market Share by Application (2018-2023)
Table 28. Global Viral Vectors Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 29. Global Viral Vectors Revenue Market Share by Application (2024-2029)
Table 30. North America Viral Vectors Revenue by Company (2021-2023) & (US$ Million)
Table 31. North America Viral Vectors Revenue by Type (2018-2023) & (US$ Million)
Table 32. North America Viral Vectors Revenue by Type (2024-2029) & (US$ Million)
Table 33. North America Viral Vectors Revenue by Application (2018-2023) & (US$ Million)
Table 34. North America Viral Vectors Revenue by Application (2024-2029) & (US$ Million)
Table 35. North America Viral Vectors Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Viral Vectors Revenue by Country (2018-2023) & (US$ Million)
Table 37. North America Viral Vectors Revenue by Country (2024-2029) & (US$ Million)
Table 38. Europe Viral Vectors Revenue by Company (2021-2023) & (US$ Million)
Table 39. Europe Viral Vectors Revenue by Type (2018-2023) & (US$ Million)
Table 40. Europe Viral Vectors Revenue by Type (2024-2029) & (US$ Million)
Table 41. Europe Viral Vectors Revenue by Application (2018-2023) & (US$ Million)
Table 42. Europe Viral Vectors Revenue by Application (2024-2029) & (US$ Million)
Table 43. Europe Viral Vectors Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Viral Vectors Revenue by Country (2018-2023) & (US$ Million)
Table 45. Europe Viral Vectors Revenue by Country (2024-2029) & (US$ Million)
Table 46. Asia Pacific Viral Vectors Revenue by Company (2021-2023) & (US$ Million)
Table 47. Asia Pacific Viral Vectors Revenue by Type (2018-2023) & (US$ Million)
Table 48. Asia Pacific Viral Vectors Revenue by Type (2024-2029) & (US$ Million)
Table 49. Asia Pacific Viral Vectors Revenue by Application (2018-2023) & (US$ Million)
Table 50. Asia Pacific Viral Vectors Revenue by Application (2024-2029) & (US$ Million)
Table 51. Asia-Pacific Viral Vectors Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 52. Asia Pacific Viral Vectors Revenue by Region (2018-2023) & (US$ Million)
Table 53. Asia Pacific Viral Vectors Revenue by Region (2024-2029) & (US$ Million)
Table 54. Latin America Viral Vectors Revenue by Company (2021-2023) & (US$ Million)
Table 55. Latin America Viral Vectors Revenue by Type (2018-2023) & (US$ Million)
Table 56. Latin America Viral Vectors Revenue by Type (2024-2029) & (US$ Million)
Table 57. Latin America Viral Vectors Revenue by Application (2018-2023) & (US$ Million)
Table 58. Latin America Viral Vectors Revenue by Application (2024-2029) & (US$ Million)
Table 59. Latin America Viral Vectors Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 60. Latin America Viral Vectors Revenue by Country (2018-2023) & (US$ Million)
Table 61. Latin America Viral Vectors Revenue by Country (2024-2029) & (US$ Million)
Table 62. Middle East and Africa Viral Vectors Revenue by Company (2021-2023) & (US$ Million)
Table 63. Middle East and Africa Viral Vectors Revenue by Type (2018-2023) & (US$ Million)
Table 64. Middle East and Africa Viral Vectors Revenue by Type (2024-2029) & (US$ Million)
Table 65. Middle East and Africa Viral Vectors Revenue by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Viral Vectors Revenue by Application (2024-2029) & (US$ Million)
Table 67. Middle East and Africa Viral Vectors Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 68. Middle East and Africa Viral Vectors Revenue by Country (2018-2023) & (US$ Million)
Table 69. Middle East and Africa Viral Vectors Revenue by Country (2024-2029) & (US$ Million)
Table 70. BioReliance Company Details
Table 71. BioReliance Business Overview
Table 72. BioReliance Viral Vectors Product and Services
Table 73. BioReliance Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 74. BioReliance Viral Vectors SWOT Analysis
Table 75. BioReliance Recent Development
Table 76. Cobra Biologics Company Details
Table 77. Cobra Biologics Business Overview
Table 78. Cobra Biologics Viral Vectors Product and Services
Table 79. Cobra Biologics Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 80. Cobra Biologics Viral Vectors SWOT Analysis
Table 81. Cobra Biologics Recent Development
Table 82. Oxford BioMedica Company Details
Table 83. Oxford BioMedica Business Overview
Table 84. Oxford BioMedica Viral Vectors Product and Services
Table 85. Oxford BioMedica Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 86. Oxford BioMedica Viral Vectors SWOT Analysis
Table 87. Oxford BioMedica Recent Development
Table 88. UniQure Company Details
Table 89. UniQure Business Overview
Table 90. UniQure Viral Vectors Product and Services
Table 91. UniQure Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 92. UniQure Viral Vectors SWOT Analysis
Table 93. UniQure Recent Development
Table 94. FinVector Company Details
Table 95. FinVector Business Overview
Table 96. FinVector Viral Vectors Product and Services
Table 97. FinVector Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 98. FinVector Viral Vectors SWOT Analysis
Table 99. FinVector Recent Development
Table 100. MolMed Company Details
Table 101. MolMed Business Overview
Table 102. MolMed Viral Vectors Product and Services
Table 103. MolMed Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 104. MolMed Viral Vectors SWOT Analysis
Table 105. MolMed Recent Development
Table 106. MassBiologics Company Details
Table 107. MassBiologics Business Overview
Table 108. MassBiologics Viral Vectors Product and Services
Table 109. MassBiologics Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 110. MassBiologics Viral Vectors SWOT Analysis
Table 111. MassBiologics Recent Development
Table 112. Richter-Helm Company Details
Table 113. Richter-Helm Business Overview
Table 114. Richter-Helm Viral Vectors Product and Services
Table 115. Richter-Helm Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 116. Richter-Helm Viral Vectors SWOT Analysis
Table 117. Richter-Helm Recent Development
Table 118. FUJIFILM Diosynth Biotechnologies Company Details
Table 119. FUJIFILM Diosynth Biotechnologies Business Overview
Table 120. FUJIFILM Diosynth Biotechnologies Viral Vectors Product and Services
Table 121. FUJIFILM Diosynth Biotechnologies Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 122. FUJIFILM Diosynth Biotechnologies Viral Vectors SWOT Analysis
Table 123. FUJIFILM Diosynth Biotechnologies Recent Development
Table 124. Lonza Company Details
Table 125. Lonza Business Overview
Table 126. Lonza Viral Vectors Product and Services
Table 127. Lonza Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 128. Lonza Viral Vectors SWOT Analysis
Table 129. Lonza Recent Development
Table 130. Aldevron Company Details
Table 131. Aldevron Business Overview
Table 132. Aldevron Viral Vectors Product and Services
Table 133. Aldevron Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 134. Aldevron Recent Development
Table 135. Eurogentec Company Details
Table 136. Eurogentec Business Overview
Table 137. Eurogentec Viral Vectors Product and Services
Table 138. Eurogentec Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 139. Eurogentec Recent Development
Table 140. Cell and Gene Therapy Catapult Company Details
Table 141. Cell and Gene Therapy Catapult Business Overview
Table 142. Cell and Gene Therapy Catapult Viral Vectors Product and Services
Table 143. Cell and Gene Therapy Catapult Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 144. Cell and Gene Therapy Catapult Recent Development
Table 145. Biovian Company Details
Table 146. Biovian Business Overview
Table 147. Biovian Viral Vectors Product and Services
Table 148. Biovian Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 149. Biovian Recent Development
Table 150. Thermo Fisher Scientific (Brammer Bio) Company Details
Table 151. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 152. Thermo Fisher Scientific (Brammer Bio) Viral Vectors Product and Services
Table 153. Thermo Fisher Scientific (Brammer Bio) Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 154. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 155. VGXI Company Details
Table 156. VGXI Business Overview
Table 157. VGXI Viral Vectors Product and Services
Table 158. VGXI Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 159. VGXI Recent Development
Table 160. PlasmidFactory Company Details
Table 161. PlasmidFactory Business Overview
Table 162. PlasmidFactory Viral Vectors Product and Services
Table 163. PlasmidFactory Viral Vectors Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
Table 164. PlasmidFactory Recent Development
Table 165. Viral Vectors Market Trends
Table 166. Viral Vectors Market Drivers
Table 167. Viral Vectors Market Challenges
Table 168. Viral Vectors Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Vectors Product Picture
Figure 2. Global Viral Vectors Market Size by Type (US$ Million): 2018 VS 2022 VS 2029
Figure 3. Global Viral Vectors Market Share by Type: 2022 VS 2029
Figure 4. Retroviral Vectors Features
Figure 5. Lentiviral Vectors Features
Figure 6. Adenoviral Vectors Features
Figure 7. Herpes Simplex Virus Vectors Features
Figure 8. Chimeric Viral Vectors Features
Figure 9. Others Features
Figure 10. Global Viral Vectors Market Size by Application (US$ Million): 2018 VS 2022 VS 2029
Figure 11. Global Viral Vectors Market Share by Application: 2022 VS 2029
Figure 12. Cancers
Figure 13. Inherited Disorders
Figure 14. Viral Infections
Figure 15. Others
Figure 16. Viral Vectors Report Years Considered
Figure 17. Global Viral Vectors Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Viral Vectors Market Size 2018-2029 (US$ Million)
Figure 19. Global Viral Vectors Market Size Market Share by Region: 2022 VS 2029
Figure 20. Global Viral Vectors Revenue Market Share by Region in 2018 VS 2022
Figure 21. Global Viral Vectors Revenue Market Share Forecast by Region (2024-2029)
Figure 22. Global Top 10 Viral Vectors Countries Ranking by Market Size (US$ Million) in 2022
Figure 23. Global Viral Vectors Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Figure 24. Global Viral Vectors Market Share by Players in 2022
Figure 25. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors as of 2022)
Figure 26. The Top 10 and 5 Players Market Share by Viral Vectors Revenue in 2022
Figure 27. North America Viral Vectors Revenue Market Share by Company in 2022
Figure 28. North America Viral Vectors Revenue Market Share by Type (2018-2029)
Figure 29. North America Viral Vectors Revenue Market Share by Application (2018-2029)
Figure 30. North America Viral Vectors Revenue Share by Country (2018-2029)
Figure 31. U.S. Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 32. Canada Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 33. Europe Viral Vectors Revenue Market Share by Company in 2022
Figure 34. Europe Viral Vectors Revenue Market Share by Type (2018-2029)
Figure 35. Europe Viral Vectors Revenue Market Share by Application (2018-2029)
Figure 36. Europe Viral Vectors Revenue Share by Country (2018-2029)
Figure 37. Germany Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 38. France Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 39. U.K. Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 40. Italy Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 41. Russia Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 42. Asia Pacific Viral Vectors Revenue Market Share by Company in 2022
Figure 43. Asia Pacific Viral Vectors Revenue Market Share by Type (2018-2029)
Figure 44. Asia Pacific Viral Vectors Revenue Market Share by Application (2018-2029)
Figure 45. Asia Pacific Viral Vectors Revenue Share by Region (2018-2029)
Figure 46. China Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 47. Japan Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 48. South Korea Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 49. India Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 50. Australia Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 51. Taiwan Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 52. Indonesia Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 53. Thailand Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 54. Malaysia Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 55. Philippines Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 56. Vietnam Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 57. Latin America Viral Vectors Revenue Market Share by Company in 2022
Figure 58. Latin America Viral Vectors Revenue Market Share by Type (2018-2029)
Figure 59. Latin America Viral Vectors Revenue Market Share by Application (2018-2029)
Figure 60. Latin America Viral Vectors Revenue Share by Country (2018-2029)
Figure 61. Mexico Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 62. Brazil Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 63. Argentina Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 64. Middle East and Africa Viral Vectors Revenue Market Share by Company in 2022
Figure 65. Middle East and Africa Viral Vectors Revenue Market Share by Type (2018-2029)
Figure 66. Middle East and Africa Viral Vectors Revenue Market Share by Application (2018-2029)
Figure 67. Middle East and Africa Viral Vectors Revenue Share by Country (2018-2029)
Figure 68. Turkey Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 69. Saudi Arabia Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 70. U.A.E Viral Vectors Revenue (2018-2029) & (US$ Million)
Figure 71. BioReliance Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 72. Cobra Biologics Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 73. Oxford BioMedica Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 74. UniQure Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 75. FinVector Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 76. MolMed Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 77. MassBiologics Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 78. Richter-Helm Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 79. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 80. Lonza Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 81. Aldevron Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 82. Eurogentec Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 83. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 84. Biovian Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 85. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 86. VGXI Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 87. PlasmidFactory Revenue Growth Rate in Viral Vectors Business (2018-2023)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
